Floatz logo

Pegylated-Proline-Interferon Alpha-2B

Polycythemia Vera

AOP Orphan Pharmaceuticals AGPhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Polycythemia Vera cohort.

Asset / SponsorPhaseRating
Ruxolitinib
University of Washington
Phase 4BB
TACROLIMUS
Thomas Jefferson University
Phase 2BB
Fludarabine
Thomas Jefferson University
Phase 2BB
Cyclophosphamide
Thomas Jefferson University
Phase 2BB
Therapeutic Allogeneic Lymphocytes
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2BB

View all 36 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →